14670 Federal Register / Vol. 89, No. 40 / Wednesday, February 28, 2024 / Notices 

Requests to participate as a speaker 

must include all of the following 

information: 

1. The name and email address of the 

person desiring to participate 

2. The organization(s) that person 

represents, if any 

3. The document(s) and primary 

article(s) of interest, listed in order of 

the speaker’s priorities 

Other Information: Written comments 

should be emailed to oga.rsvp@hhs.gov 

with the subject line ‘‘Written Comment 

Re: Stakeholder Listening Session on 

public health emergencies preparedness 

and response negotiations’’ by 

Wednesday, April 17, 2024. 

We look forward to your comments on 

these matters. 

Dated: February 22, 2024. 

Susan Kim, 

Principal Deputy Assistant Secretary. 

[FR Doc. 2024–04080 Filed 2–27–24; 8:45 am] 

BILLING CODE 4150–38–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Government-Owned Inventions; 

Availability for Licensing 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: The invention listed below is 

owned by an agency of the U.S. 

Government and is available for 

licensing to achieve expeditious 

commercialization of results of 

federally-funded research and 

development. Foreign patent 

applications are filed on selected 

inventions to extend market coverage 

for companies and may also be available 

for licensing. 

FOR FURTHER INFORMATION CONTACT: 

Wade Green at (301) 761–7505 or 

greenww@nih.gov. Licensing 

information may be obtained by 

communicating with the Technology 

Transfer and Intellectual Property 

Office, National Institute of Allergy and 

Infectious Diseases, 5601 Fishers Lane, 

Rockville, MD 20852: tel. 301–496– 

2644. A signed Confidential Disclosure 

Agreement will be required to receive 

copies of unpublished information 

related to the invention. 

SUPPLEMENTARY INFORMATION: 

Technology description follows: 

An Innovative Adapter for Expedited 

and Automated Thawing of viably 

Frozen Cells. 

Description of Technology 

This technology is a device and 

system for expediting the thawing 

frozen specimens (e.g., cryopreserved 

cells) contained in cryo-vials, offering a 

breakthrough solution for researchers 

seeking efficiency and precision in their 

workflows. The device is equipped with 

a small elongated tubular adaptor that 

suspends a cryo-vial of frozen cells over 

a centrifuge tube containing culture 

medium in an inverted position. With a 

focus on speed, efficiency and 

automation, the adaptor dramatically 

expedites the process of recovering 

viable cells from frozen specimens. It 

reduces per-sample labor time for 

thawing from several minutes to a few 

seconds, enabling a single technician to 

simultaneously thaw multiple vials 

within the capacity of centrifuges. The 

cells, once thawed, are diluted instantly 

into growth medium contained in the 

centrifuge tubes and spend essentially 

no time in liquid cryopreservative. 

The automated mechanism ensures a 

precise and controlled thawing 

environment maintaining optimal 

temperature conditions throughout the 

thawing process. 

Potential Commercial Applications: 

• This device can be used in sample 

preparation and cell culturing. 

• Applicable for research materials, 

medical and non-medical devices and 

consumer products. 

Competitive Advantages: 

• Provides a faster process of 

recovering viable cells from frozen 

specimens. 

• Eliminates multi-step processes. 

• High throughput system with 

reduced variability. 

• Constant environment control. 

Development Stage: 

• Prototype 

Inventors: Dr. Mario Roederer, Dr. 

Pratip Chattopadhyay and Margaret 

Beddall, all of NIAID. 

Publications: n/a. 

Intellectual Property: HHS Reference 

No. E–080–2015–0–EIR–00 U.S. Patent 

Application No. 14/661,449, filed on 

March 18, 2015; Published Patent 

Application US20160274004A1 on 

September 22, 2016; U.S. Patent 

9,663,812 issued May 30, 2017. 

Licensing Contact: To license this 

technology, please contact Wade Green 

at (301) 761–7505 or greenww@nih.gov. 

and reference E–080–2015. 

Collaborative Research Opportunity: 

The National Institute of Allergy and 

Infectious Diseases is seeking statements 

of capability or interest from parties 

interested in collaborative research to 

further develop, evaluate, or 

commercialize this technology. For 

collaboration opportunities, please 

contact Wade Green at (301) 761–7505 

or greenww@nih.gov. 

Dated: February 7, 2024. 

Surekha Vathyam, 

Deputy Director, Technology Transfer and 

Intellectual Property Office, National Institute 

of Allergy and Infectious Diseases. 

[FR Doc. 2024–04060 Filed 2–27–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Environmental 

Health Sciences; Notice of Closed 

Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Environmental Health Sciences Special 

Emphasis Panel; Career Development in K 

Applications. 

Date: March 20–21, 2024. 

Time: 10:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Environmental 

Health Science, 530 Davis Drive, Keystone 

Building, Durham, NC 27713 (Virtual 

Meeting). 

Contact Person: Beverly W. Duncan, Ph.D., 

Scientific Review Officer, Division of 

Extramural Research and Training, National 

Institute of Environmental Health Science, 

Keystone Building, 530 Davis Drive, Room 

3130, Durham, NC 27713, (240) 353–6598, 

beverly.duncan@nih.gov. 

Name of Committee: National Institute of 

Environmental Health Sciences Special 

Emphasis Panel; Exposome Research 

Coordination to Accelerate Precision 

Environmental Health (PEH). 

Date: April 3, 2024. 

Time: 10:30 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Environmental 

Health Science, 530 Davis Drive, Keystone 

Building, Durham, NC 27713 (Virtual 

Meeting). 

Contact Person: Leroy Worth, Ph.D., 

Scientific Review Officer, Scientific Review 


ddrumheller on DSK120RN23PROD with NOTICES1